Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Voronoi selects CDD Vault platform to manage its Drug Discovery Data 2019-08-23 06:36
Biotech Conagen Acquires Production Platform of Therapeutic Proteins 2019-08-22 01:39
CMAB and Kintor Announce a New Comprehensive Collaboration to Develop and Manufacture the ALK-1 Monoclonal Antibody 2019-08-21 21:35
Global Cord Blood Corporation to Report First Quarter Fiscal 2020 Financial Results 2019-08-21 19:00
NeuroVive Pharmaceutical AB Interim Report January - June 2019 2019-08-21 15:24
WuXi Biologics Reports Outstanding Interim Results 2019-08-19 22:09
WuXi AppTec Reports First Half 2019 Interim Results 2019-08-19 19:20
Abstract on CStone's CS1001-101 trial accepted for poster presentation at ESMO 2019 Annual Congress 2019-08-19 13:50
Conagen Expands Portfolio Beyond Gamma-Decalactone to 20 new non-GMO Lactones 2019-08-13 03:47
Higher Levels of Automation Expand Revenue Potential for Analytical Instrumentation Manufacturers 2019-08-13 00:19
New Publication Shows Different Result of Risk Classification between GenesWell BCT and Oncotype DX in Breast Cancer Patients 50 Years Old or Younger. 2019-08-12 21:00
Samsung BioLogics Implements Large Scale N-1 Perfusion for Commercial Application 2019-08-12 19:00
The iQ Group Global named one of Australia's Top 5 Most Innovative Companies 2019 2019-08-09 18:46
OssDsign AB (publ) Initiates Commercial Preparations for Launch in Japan Following Regulatory Filing for OssDsign Cranial 2019-08-09 14:57
EnGeneIC Wins Innovation Award from Australian Financial Review 2019-08-09 12:49
DiscGenics Announces First Patients Treated in Japanese Clinical Trial of Cell Therapy for Degenerative Disc Disease 2019-08-07 21:00
Corteva Agriscience Launches in Myanmar to Serve Farmers Better with the Newest Innovation in Seed and Crop Protection Technologies 2019-08-07 10:30
LUCA Biologics Launches to Develop Live Biotherapeutics for Women's Health Starting with Urinary Tract Infection (UTI) 2019-08-06 18:00
China Biologic Reports Financial Results for the Second Quarter of 2019 2019-08-06 04:30
Ascletis Received IND Approval and Management Outlook of 2019 and Beyond 2019-08-05 08:00
1 275 276 277 278 279 415